Are there any suppliers suitable for IVD raw materials among the top ten reagent companies?

There are not many of the top ten scientific research reagents that are truly suitable for IVD raw materials, but there are also some. Companies with industrial raw material lines such as Merck/Sigma, Thermo, Meridian, Medix, and Hytest can provide more complete COA and inter batch consistency documents. Domestically, Feipeng, Hanhai New Enzyme, Nearshore, and Yisheng have made significant progress in chemiluminescence raw materials, making delivery and pricing more suitable for pilot testing. The key is to clarify whether the supplier's raw materials have undergone diagnostic platform validation or have only been used for scientific research applications. The amount of 50mg antibody is not considered large, and many raw material factories can produce it according to the milligram level pilot specifications, requiring them to provide concentration, purity, affinity, paired signal-to-noise ratio, and accelerated stability data.

When switching to chemiluminescence, raw material stability is more important than price. It is recommended to prioritize suppliers with ISO 13485 or at least those who can provide batch-to-batch consistency procedure documents, so that traceability can be maintained for future registration or quality system purposes. If the lead time is within one month, you can require the supplier to commit to batch number locking and retention samples, and after arrival, perform your own inspection of key indicators such as appearance, concentration, and endotoxin. Domestic raw material manufacturers usually have faster lead times, but some small manufacturers have incomplete documentation systems; imported raw materials have complete documentation but slower lead times. You can validate 2-3 suppliers simultaneously, have each use the same batch of calibrators for pairing, and finally score based on signal-to-noise ratio, batch-to-batch CV, delivery, and documentation completeness. Do not assume suitability for diagnostics just because a supplier ranks in the top ten for research.

Antibodies used as IVD raw materials and research antibodies are not the same thing. When purchasing, you must ask the supplier to provide the CoA and batch-to-batch consistency report for that lot, which should at least include purity, concentration, batch-to-batch CV, cross-reactivity, and recommended pairing. If the supplier can only provide a simple SDS-PAGE image, be cautious. It is recommended to first request 1-2 mg samples for pairing and signal-to-noise ratio testing on the chemiluminescence platform, while also evaluating whether the batch-to-batch consistency data match your own platform. You should also confirm whether the antibodies come from an animal-origin-free or low-endotoxin process; although this may not be necessary for pilot-scale production, it can save a lot of trouble during scale-up. If the lead time is within one month, prioritize domestic suppliers with pilot production lines; imported raw materials may require additional time for customs clearance.

It is recommended to choose magnetic beads and substrates separately, rather than just focusing on one company for packaging. Magnetic beads focus on particle size uniformity, carboxyl density, magnetic response time, inter batch differences, and sealing process. When selecting, ask the supplier to provide trial kits of different particle sizes and measure the background and signal-to-noise ratio on your chemiluminescence platform. The substrate raw materials should pay attention to the signal window, bottle stability, and compatibility with the antibody/magnetic bead system. Some AP substrates and AE substrates have significant differences and cannot be used interchangeably. During the pilot phase, do not lock all the raw materials at once. First, conduct a small orthogonal experiment and wait for the signal values to stabilize before amplifying. If the budget of 100000 li includes magnetic beads, substrates, and antibody validation, sufficient validation costs should be allocated.